Want to see SE:EGTX full AI Analyst Report?

Egetis Therapeutics AB (EGTX) Revenue

2 Followers

Egetis Therapeutics AB Revenue

Egetis Therapeutics AB had a revenue of 17.40M in the quarter ending Jun 30, 2026, with 29.85%. This bring the company's revenue in the last twelve months to 66.10M, Decreased 4.59%. In the fiscal year ending Dec 31, 2025, Egetis Therapeutics AB had annual revenue of 62.40M with 35.36% growth.

Revenue (ttm)

66.10M

Revenue Growth

39.45%

P/S Ratio

70.34

Revenue/Employee

kr1,114,286

Employees

Market Cap

kr4.39B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	62.40M	16.30M	+35.36%
Dec 31, 2024	46.10M	-11.50M	-19.97%
Dec 31, 2023	57.60M	35.10M	+156.00%
Dec 31, 2022	22.50M	-15.74M	-41.17%
Dec 31, 2021	38.24M	-2.42M	-5.95%
Dec 31, 2020	40.66M	-41.90M	-50.75%
Dec 31, 2019	82.56M	54.35M	+192.66%
Dec 31, 2018	28.21M	14.63M	+107.66%
Dec 31, 2017	13.59M	―	―